Source: Acta dermato-venereologica. Unidade: FM
Subjects: PSORÍASE, DERMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ORTIGOSA, Luciena C. M. et al. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, v. 94, n. 1, p. 26-31, 2014Tradução . . Disponível em: https://doi.org/10.2340/00015555-1650. Acesso em: 02 nov. 2024.APA
Ortigosa, L. C. M., Silva, L. C. R., Duarte, A. J. S., Takahashi, M. D. F., & Bebrad, G. (2014). Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, 94( 1), 26-31. doi:10.2340/00015555-1650NLM
Ortigosa LCM, Silva LCR, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2340/00015555-1650Vancouver
Ortigosa LCM, Silva LCR, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2024 nov. 02 ] Available from: https://doi.org/10.2340/00015555-1650
